Module 8: References and Image Credits


Begun, A.L. (2020). Introduction to psychoactive substances. In A.L. Begun & M.M. Murray, (Eds.), Routledge handbook of social work and addictive behavior. London: Routledge.

Brandlistuen, R.E., Ystrom, E., Herńandez-Diaz, S., Skurtveit, S., Selmer, R.M., Handal, M., & Nordeng, H. (2017). Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study. PLos One, 12(7), e0181042. Doi:10.1371/journal.pone.0181042

Chakraborty, K., Neogi, R., & Basu, D. (2011). Club drugs: Review of the ‘rave’ with a note of concern for the Indian scenario. Indian Journal of Medical Research, 133(5), 594-604.

Dupont, R.L., & Dupont, C.M. (2005). Sedative/hypnotics and benzodiazepines. In R.J. Frances, S.I. Miller, & A.H. Mack, (Eds.), Clinical textbook of addictive disorders, third ed., (pp. 219-242). NY: Guilford Press.

McElhatton, P.R. (1994). The effects of benzodiazepine use during pregnancy and lactation. Reproductive Toxicology, 8(6), 461-475.

National Institute on Drug Abuse (NIDA). (2018). Prescription CNS depressants. National Institutes of Health, U.S. Department of Health and Human Services. Retrieved from

Substance Abuse and Mental Health Services Administration (SAMHSA). (2019). National Survey on Drug Use and Health (NSDUH) 2018 detailed tables. Retrieved from

Image Credits

Image of Dr. Nora Volkow with “Addiction is a disease that can be treated…” sign: from NIDA, January 22, 2019.


Icon for the Creative Commons Attribution-NonCommercial 4.0 International License

SWK 5805: Theories and Biological Basis of Substance Misuse Copyright © by Dr. Audrey Begun is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, except where otherwise noted.

Share This Book